Faculty profile

John de Almeida

ResearcherRadiation OncologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

John de Almeida

Researcher

Radiation Oncology

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
36 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adaptive Therapy Ctdna De-Escalation Head And Neck Cancer Hpv Personalized Medicine Radiotherapy Surgery

Latest papers

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2026
Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes · 2026
Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.
Head & neck · 2026

All 58 publications

Latest funding

The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer
CIHR · 2025 · Principal investigator
$1,071,000

All 1 grants and awards

58 publications.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Rühle A, Sanz-Garcia E, Su J, O'Sullivan B, Waldron JN, Spreafico A, Siu L, Eng L, McPartlin A, Bayley A, Bratman SV, Hahn E, Hope A, Hosni A, Malik N, Tsai J, de Almeida J, Xu W, Kim J, Huang SH

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111769 PMID: 42697275

Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.

Johari MH, Bartlett E, Su J, O'Sullivan B, Weinreb I, Smith S, de Almeida J, Yao CMKL, Kim J, Bayley A, Yu E, Huang SH

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes2026

DOI: 10.1177/08465371261465409 PMID: 42544572

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Chelvarajah RC, Chee LYS, Su J, O'Sullivan B, Yao CMKL, Sanz-Garcia E, Smith SM, Weinreb I, Bratman S, Cho BCJ, Hahn E, Hope A, Hosni A, Kim J, McPartlin A, Malik N, Tsai CJ, de Almeida J, Spreafico A, Tong L, Huang SH, Waldron JN

Head & neck2026

DOI: 10.1002/hed.70230 PMID: 41816946

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.

Icht O, Sun A, Wong P, McPartlin A, Muniz TP, Spreafico A, Saibil SD, Lukens JN, Karam SD, De Almeida J, Butler MO, Tsai CJ

Frontiers in oncology2026

DOI: 10.3389/fonc.2026.1841070 PMID: 42518820

Assessing Financial Toxicity in Cancer: A Global Systematic Review and Meta-Analysis Using an Asset Framework.

Kacker S, Najjar W, Stemme R, Samaha NL, Yenokyan G, Armache M, Hearn M, Dorris CS, Todsen T, De Almeida J, Fagan J, Mehanna H, Fakhry C, Gharzai LA, Gupta S, Ettman CK, Mady LJ

Cancer medicine2026

DOI: 10.1002/cam4.72082 PMID: 42387329

Validation of the ninth edition pathological and clinical TNM classifications for salivary gland carcinoma.

Alsulami S, Rühle A, Yu E, Su J, O'Sullivan B, Hosni A, Waldron JN, Weinreb I, Smith S, de Almeida J, Goldstein D, Yao CM, McPartlin A, Bayley A, Bratman SV, Hahn E, Hope A, Kim J, Malik N, Sanz-Garcia E, Spreafico A, Tong L, Xu W, Bartlett E, Huang SH

Oral oncology2026

DOI: 10.1016/j.oraloncology.2026.108140 PMID: 42732755

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Johari MH, Rühle A, Su J, O'Sullivan B, Yu E, Waldron JN, McPartlin A, Bayley A, Bratman SV, Sanz-Garcia E, Spreafico A, de Almeida J, Hahn E, Hope A, Hosni A, Kim J, Malik N, Xu W, Bartlett E, Huang SH

International journal of radiation oncology, biology, physics2026

DOI: 10.1016/j.ijrobp.2025.12.032 PMID: 41448500

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Moharrami M, Watson E, Huang SH, Madathil S, Kim J, McPartlin A, Malik NH, Singhal S, Hahn E, Waldron J, Bratman S, de Almeida J, Yao C, Hope A, Quinonez C, Glogauer M, Hosni A

Journal of medical systems2026

DOI: 10.1007/s10916-026-02359-4 PMID: 41801474

Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma.

Rooney CM, Huang SH, Su J, Bratman S, Cho J, de Almeida J, Glogauer M, Goldstein D, Hahn E, Hosni A, Hope A, Irish J, Kim J, O'Sullivan B, Ringash J, Spreafico A, Tsai J, Waldron J, Yao C, Watson E, McPartlin A

Head & neck2025

DOI: 10.1002/hed.27988 PMID: 39474724

Buccal fat applied to transoral robotic lateral oropharyngectomy defects to lessen radical tonsillectomy pain (BOLT): a single-centre, phase II, parallel, randomised control trial study protocol.

Xie M, de Almeida J, Goldstein D, Martino R, Liu YF, Allen B, Xu W, Hueniken K, Yao CM

BMJ open2025

DOI: 10.1136/bmjopen-2025-106125 PMID: 41387003

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Adaptive Therapy Dear Professor de Almeida, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

John de Almeida

Research

Latest papers

Latest funding

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Diagnostic Performance of CT/MRI-Based Lymph Node Morphology With Three-Plane Size Measurements in Oral Cavity Cancer.

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) -&#xa0;a single arm, phase 2 clinical trial.

Assessing Financial Toxicity in Cancer: A Global Systematic Review and Meta-Analysis Using an Asset Framework.

Validation of the ninth edition pathological and clinical TNM classifications for salivary gland carcinoma.

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma.

Buccal fat applied to transoral robotic lateral oropharyngectomy defects to lessen radical tonsillectomy pain (BOLT): a single-centre, phase II, parallel, randomised control trial study protocol.

The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer

Frequent collaborators

Wei Xu

Andrew Hope

John Kim

Anna Spreafico

Scott Bratman

Antoine Eskander

Meredith Giuliani

Enrique Sanz Garcia

Ian Witterick

Jonathan Irish

Geoffrey Liu

Christopher Yao

Lawson Eng

Lillian Siu

Michael Glogauer

Lorne Parnes

Jason Archibald

Rosemary Martino

Paul Mick

Sonica Singhal

Sreenath Madathil

Joseph Dort

Michael Gupta

Houda Bahig

Carlos Quiñonez

Osvaldo Espin Garcia

Lisa Avery

Osvaldo Espin Garcia

Julie Strychowsky

Marc Gaudet

Matthew Cecchini

Danny Enepekides

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial.